Skip to main content

Western Sierra Resource Corporation (WSRC)

New York Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
43.8Fair

ValueMarkers Composite Index

Top 11%#39,980 of 44,722

DCF data not available

Piotroski
4/9
Neutral
Beneish
-3.41
Low Risk
Altman
-0.71
Distress
DCF Value
-
N/A
ROIC
0.3%
Low
P/E
0.1
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Western Sierra Resource Corporation (WSRC) — VMCI valuation read

Composite valuation read on WSRC: VMCI 44/100 against a Healthcare sector median of 50. The 6-point below-median print is the headline number for Western Sierra Resource Corporation, and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for WSRC: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on WSRC: WSRC trades at 27.0x earnings, 50% above the Healthcare median of 18.0x; ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%); net debt to EBITDA of -1.2x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

WSRC rose 3.9% over the trailing 7 days, with a +0.1% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.